The estimated Net Worth of Jill Leversage is at least 244 千$ dollars as of 21 May 2024. Ms. Leversage owns over 5,610 units of Aurinia Pharmaceuticals Inc stock worth over 84,355$ and over the last 4 years she sold AUPH stock worth over 32,201$. In addition, she makes 126,980$ as Independent Director at Aurinia Pharmaceuticals Inc.
Jill has made over 5 trades of the Aurinia Pharmaceuticals Inc stock since 2021, according to the Form 4 filled with the SEC. Most recently she sold 5,610 units of AUPH stock worth 32,201$ on 21 May 2024.
The largest trade she's ever made was exercising 8,733 units of Aurinia Pharmaceuticals Inc stock on 18 May 2023 worth over 57,026$. On average, Jill trades about 2,863 units every 173 days since 2021. As of 21 May 2024 she still owns at least 12,918 units of Aurinia Pharmaceuticals Inc stock.
You can see the complete history of Ms. Leversage stock trades at the bottom of the page.
Jill Diane Leversage serves as Independent Director of the Company. Ms. Jill Leversage was appointed as an independent director in November 2019. Prior to her retirement, Ms. Leversage was a senior investment banker with over 30 years of experience in investment banking and private equity. Ms. Leversage was a Managing Director, Corporate and Investment Banking for TD Securities Inc. and Former Managing Director at Highland West Capital Ltd. She currently serves on several public and private company boards. Ms. Leversage is a fellow of the Institute of Chartered Professional Accountants of British Columbia and also a Chartered Business Valuator (ret.) of the Canadian Institute of Chartered Business Valuators.
As the Independent Director of Aurinia Pharmaceuticals Inc, the total compensation of Jill Leversage at Aurinia Pharmaceuticals Inc is 126,980$. There are 17 executives at Aurinia Pharmaceuticals Inc getting paid more, with Peter Greenleaf having the highest compensation of 1,678,600$.
Jill Leversage is 63, she's been the Independent Director of Aurinia Pharmaceuticals Inc since 2019. There are 4 older and 10 younger executives at Aurinia Pharmaceuticals Inc. The oldest executive at Aurinia Pharmaceuticals Inc is George Milne, 76, who is the Independent Chairman of the Board.
Jill's mailing address filed with the SEC is #140, 14315 - 118 AVENUE, , EDMONTON, A0, T5L 4S6.
Over the last 4 years, insiders at Aurinia Pharmaceuticals Inc have traded over 22,019,765$ worth of Aurinia Pharmaceuticals Inc stock and bought 107,125 units worth 893,295$ . The most active insiders traders include Timothy P Walbert、Michael R Hayden、Michael Robert Martin. On average, Aurinia Pharmaceuticals Inc executives and independent directors trade stock every 18 days with the average trade being worth of 193,451$. The most recent stock trade was executed by Scott Michael Habig on 6 August 2024, trading 18,249 units of AUPH stock currently worth 96,902$.
aurinia pharmaceuticals is a biotechnology company located in 5120-75 street, edmonton, canada.
Aurinia Pharmaceuticals Inc executives and other stock owners filed with the SEC include: